Results 241 to 250 of about 4,600,401 (406)

Anticoagulant therapy in COVID-19: A narrative review. [PDF]

Clin Transl Sci, 2023
Mohseni Afshar Z, Tavakoli Pirzaman A, Hosseinzadeh R, Babazadeh A, Taghizadeh Moghadam MA, Miri SR, Sio TT, Sullman MJM, Barary M, Ebrahimpour S.   +9 more
europepmc   +1 more source

Anterior mediastinal haematoma and left haemothorax on well-controlled oral anticoagulant therapy [PDF]

, 1983
M Abaskaron, Grace Peterson, Tsung-Yao Huang   +2 more
openalex   +1 more source

A Modified Quick's One-stage Test for the Control of Out-patients on Anticoagulant Therapy

, 1960
Benjamin Thompson
openalex   +1 more source

A Benchmark, Expand, and Calibration (BenchExCal) Trial Emulation Approach for Using Real‐World Evidence to Support Indication Expansions: Design and Process for a Planned Empirical Evaluation

Clinical Pharmacology &Therapeutics, EarlyView.
Real‐world evidence involving healthcare database studies is well established for making causal inferences in post‐market drug safety studies and methods, data, and research infrastructure for evaluating effectiveness have advanced in recent years. The rapidly expanding field of etiologic research using insurance claims and electronic health records ...
Shirley V. Wang, Massimiliano Russo, Robert J. Glynn, Marie C. Bradley, Jiwei He, John Concato, Sebastian Schneeweiss   +6 more
wiley   +1 more source

Evaluation of Chitosan-Based Axiostat as Hemostatic Dressing for Endovascular Procedures in Patients with Leriche Syndrome on Anticoagulant Therapy. [PDF]

Pharmaceuticals (Basel)
Perri P, Curcio F, De Luca M, Piro P, Trombino S, Cassano R.   +5 more
europepmc   +1 more source

Control of Oral Anticoagulant Therapy, with Special Reference to Quick Test and Thrombotest : Symposium on Heart Diseases and Anticoagulants

, 1963
Kiyoto Satake
openalex   +2 more sources

Impact of Age and Factor Xa Inhibitor Concentrations on Bleeding Risk in Patients with Atrial Fibrillation

Clinical Pharmacology &Therapeutics, EarlyView.
This study aimed to analyze differences in the exposure‐response relationship for factor Xa inhibitors (FXaI) between patients aged ≥ 80 and < 80 years. Patients with atrial fibrillation (AF) taking rivaroxaban, apixaban, or edoxaban were enrolled, and a single steady‐state trough concentration was measured.
Shin‐Yi Lin, Yen‐Bing Liu, Li‐Ting Ho, Ching‐Hua Kuo, Yu‐Fong Peng, Chih‐Fen Huang, Sung‐Chun Tang, Jiann‐Shing Jeng   +7 more
wiley   +1 more source

Clinical outcomes and hemorrhagic or thromboembolic risks in decompressive craniectomy for patients taking antiplatelet or anticoagulant therapy. [PDF]

Neurosurg Rev
Scerrati A, Scanferla G, Sgarbanti L, Mantovani G, Angelini C, Flacco ME, Maugeri R, Bonosi L, Iacopino DG, Tumbiolo S, Adorno A, Brunasso L, Lofrese G, Rosetti V, Tosatto L, Somma T, Cavallo LM, Lombardi S, Sturiale CL, Signorelli F, Auricchio AM, Menna G, Ricciardi L, Montemurro N, Raneri F, Rustemi O, Zambon G, Cavallo MA, De Bonis P.   +28 more
europepmc   +1 more source

Studies on the Methods of Control and of Administration of Drugs for Anticoagulant Therapy : Symposium on Heart Diseases and Anticoagulants

, 1963
Manabu D. Yamanaka
openalex   +2 more sources

Effect of Laboratory Variation in the Prothrombin-Time Ratio on the Results of Oral Anticoagulant Therapy [PDF]

, 1993
Mark H. Eckman, Herbert J. Levine, Stephen G. Pauker   +2 more
openalex   +1 more source